target-based screening

Target-based screening is a drug discovery approach that focuses on identifying compounds that interact with a specific molecular target, such as a protein or enzyme, believed to be involved in a disease pathway. This method contrasts with phenotypic screening, which observes effects in whole cells or organisms without prior knowledge of the target. Discussions on WindowsForum.com explore the ongoing debate between target-based and phenotypic screening, highlighting that each approach has distinct advantages and limitations. The field has shifted between these strategies over the past two decades, with renewed interest in phenotypic methods reflecting the complexity of biological systems. Target-based screening remains a cornerstone of modern drug discovery, particularly when the molecular basis of a disease is well understood.